Locations
Copenhagen, Denmark
industry
Biotechnology · DeepTech
Size
1 - 10 employees
Stage
Seed
founded in
2020
Pephexia Therapeutics is a biotechnology company focused on the discovery and development of novel peptide-based pharmacotherapies aimed at treating cachexia, sarcopenia, and related diseases. The company addresses a significant unmet medical need in cancer cachexia, which affects up to 80% of cancer patients and is a leading cause of mortality. By leveraging naturally occurring peptide hormones, Pephexia aims to provide effective and convenient treatment options that improve the quality of life and survival rates for patients suffering from these debilitating conditions. With a strong team of experienced professionals and ongoing collaborations, Pephexia is well-positioned to make a meaningful impact in the biopharmaceutical landscape.
Something looks off?